This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
